These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 38025054)
1. Retraction: Corrigendum: Design, synthesis, and biological evaluation of (E)-N'-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents. Frontiers Editorial Office Front Chem; 2023; 11():1332618. PubMed ID: 38025054 [TBL] [Abstract][Full Text] [Related]
2. Retraction: Design, synthesis, and biological evaluation of (E)-N'-((1-chloro-3,4-dihydronaphthalen-2-yl)methylene)benzohydrazide derivatives as anti-prostate cancer agents. Frontiers Editorial Office Front Chem; 2023; 11():1332615. PubMed ID: 38033470 [TBL] [Abstract][Full Text] [Related]
3. Corrigendum: Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents. Arjun HA; Elancheran R; Manikandan N; Lakshmithendral K; Ramanathan M; Bhattacharjee A; Lokanath NK; Kabilan S Front Chem; 2019; 7():804. PubMed ID: 31840023 [TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents. Arjun HA; Elancheran R; Manikandan N; Lakshmithendral K; Ramanathan M; Bhattacharjee A; Lokanath NK; Kabilan S Front Chem; 2019; 7():474. PubMed ID: 31355179 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, magnetic and photomagnetic study of new iron(II) spin-crossover complexes with N₄O₂ coordination sphere. Zhang L; Xu GC; Xu HB; Mereacre V; Wang ZM; Powell AK; Gao S Dalton Trans; 2010 May; 39(20):4856-68. PubMed ID: 21491699 [TBL] [Abstract][Full Text] [Related]
6. Retraction: Synthesis of bioactive yttrium-metal-organic framework as efficient nanocatalyst in synthesis of novel pyrazolopyranopyrimidine derivatives and evaluation of anticancer activity. Frontiers Editorial Office Front Chem; 2023; 11():1285225. PubMed ID: 37731453 [TBL] [Abstract][Full Text] [Related]
7. Erratum: 2-Hydr-oxy-N'-[(E)-(3-hydr-oxy-2-naphth-yl)methyl-ene]benzohydrazide. Corrigendum. Sun Y; Li HG; Wang X; Fu S; Wang D Acta Crystallogr Sect E Struct Rep Online; 2009 Jul; 65(Pt 8):e21. PubMed ID: 21583291 [TBL] [Abstract][Full Text] [Related]
8. Retraction: Synthesis of efficient cobalt-metal organic framework as reusable nanocatalyst in the synthesis of new 1,4-dihydropyridine derivatives with antioxidant activity. Frontiers Editorial Office Front Chem; 2023; 11():1285183. PubMed ID: 37731455 [TBL] [Abstract][Full Text] [Related]
16. Retraction: Spectroscopic and molecular modeling studies of binding interaction between the new complex of yttrium and 1,10-phenanthroline derivatives with DNA and BSA. Frontiers Editorial Office Front Chem; 2024; 12():1433667. PubMed ID: 38835724 [TBL] [Abstract][Full Text] [Related]
17. DNA binding properties and cell viabilities of metal complexes derived from (E)-2-hydroxy-N'-((thiophen-2-yl)methylene)benzohydrazone and (E)-N'-((thiophen-2-yl)methylene)isonicotinylhydrazone. Liu YC; Luo J; Wang SY; Liang ZX; Zhang X; Wang BD; Li YY; Lei RX; Wang JY; Zhao GP; Bai CX; Chen H Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5356-5369. PubMed ID: 37401270 [TBL] [Abstract][Full Text] [Related]